Third Party Pharma Manufacturing in India: Complete Guide
The pharmaceutical industry in India offers significant opportunities for pharmaceutical marketers, distributors, healthcare entrepreneurs and established medicine brands.
As competition increases and businesses look for efficient ways to expand their product portfolios, third party pharma manufacturing in India has become an important business model.
Instead of investing in a manufacturing plant, machinery, production infrastructure and a complete in-house manufacturing team, companies can partner with an appropriately licensed pharmaceutical manufacturer to produce medicines under an agreed arrangement.
This approach allows businesses to concentrate on branding, marketing, distribution, customer relationships and market development while an eligible manufacturing partner manages the agreed production activities.
Whether you are planning to launch a new pharmaceutical brand or expand an existing product range, understanding the manufacturing process, regulatory requirements, quality standards and supplier selection criteria is essential.
In this comprehensive guide, we explain how third party pharmaceutical manufacturing works, its major benefits, the types of products available, the factors affecting manufacturing costs and how to select a suitable manufacturing partner in India.
What Is Third Party Pharma Manufacturing?
Third party pharma manufacturing is a business arrangement in which one company engages another appropriately licensed pharmaceutical manufacturer to manufacture and, where agreed, package pharmaceutical products.
The business commissioning the products generally focuses on its brand, commercial strategy, distribution and customer network. The manufacturing partner performs the activities specified in the agreement, which may include production planning, manufacturing, quality control, packaging and dispatch.
The exact responsibilities depend on the product, applicable regulations, licences, contractual terms and the capabilities of the manufacturing facility.
For example, a pharmaceutical marketing company may want to introduce a range of tablets, capsules, syrups or topical formulations. Rather than establishing its own factory, it can explore working with an eligible third party pharmaceutical manufacturing company.
This model is also commonly associated with contract manufacturing. However, third party manufacturing, contract manufacturing and loan licensing can involve different legal and operational arrangements. Businesses should confirm which structure applies to their particular requirements.
How Does Third Party Pharma Manufacturing Work in India?
The third party pharmaceutical manufacturing process generally involves several stages, from initial product planning to final delivery.
1. Identify Your Product Requirements
The first step is to decide which pharmaceutical products you want to launch or expand.
Prepare a product list that includes the proposed formulation, dosage form, strength, pack size and expected order quantity. You should also identify the intended market and any specific packaging or quality requirements.
A clear product brief helps manufacturers assess feasibility and prepare a more relevant quotation.
2. Select a Suitable Manufacturing Partner
Research pharmaceutical manufacturers that have the appropriate licences, product capabilities, quality systems and infrastructure for your requirements.
Check whether the manufacturer can handle your proposed dosage forms and whether the relevant products and manufacturing activities fall within its approved scope.
Do not rely exclusively on marketing claims. Request appropriate documentation and verify credentials before placing an order.
3. Discuss Quotations and Commercial Terms
Once the product requirements are clear, request a detailed quotation.
The quotation may depend on the formulation, raw materials, production batch size, packaging specifications, testing requirements, order quantity and delivery location.
Clarify the payment schedule, lead time, artwork approval process, taxes, transportation arrangements and procedures for handling delays or quality complaints.
4. Complete Documentation and Regulatory Checks
Before manufacturing begins, confirm the applicable regulatory pathway and documentation.
Depending on the product and business arrangement, this may include manufacturing licences, product permissions, brand or trademark documentation, approved artwork, purchase orders, quality agreements and other applicable records.
Requirements vary by product category and the role of each business. Confirm the relevant obligations with the manufacturer and a qualified regulatory professional.
5. Approve Packaging and Product Specifications
Packaging is an important part of product development. The parties should agree on the product label, carton, blister or bottle, pack size, batch coding and other required particulars.
All artwork should be reviewed for applicable labelling and regulatory requirements before production. Avoid printing unverified claims, incorrect compositions or unsupported certifications.
6. Manufacturing and Quality Control
The manufacturer carries out the agreed production activities under its applicable quality system and approved procedures.
Quality checks may include raw material testing, in-process controls, finished-product testing, packaging inspections and documentation review, as applicable to the product.
The scope of testing and release requirements should be agreed upon and documented.
7. Final Release and Delivery
Following the required quality and documentation checks, the product can be released through the applicable procedures and dispatched according to the agreed terms.
The buyer should confirm the received quantity, batch details, packaging condition and supporting documents.
A well-defined process improves transparency and helps establish a long-term manufacturing relationship.
Key Benefits of Third Party Pharma Manufacturing
1. Lower Investment in Manufacturing Infrastructure
Setting up a pharmaceutical manufacturing facility requires investment in premises, equipment, utilities, qualified personnel, quality systems and regulatory compliance.
Third party manufacturing can reduce the need for a business to make these investments itself. Instead, resources can be allocated to product development, distribution, sales and marketing.
Actual savings depend on the products, order quantities and commercial arrangement.
2. Opportunity to Build Your Own Pharmaceutical Brand
Businesses can explore launching products under their own brands through suitable manufacturing arrangements.
This gives pharmaceutical marketers and distributors an opportunity to develop brand recognition, establish customer relationships and build a differentiated product portfolio without necessarily owning a factory.
Brand ownership, intellectual property rights and permitted product claims should be addressed clearly in the relevant agreements.
3. Access to Established Manufacturing Capabilities
An appropriately equipped manufacturer may already have the machinery, production systems and trained personnel required for specific dosage forms.
Partnering with such a facility can help a business avoid duplicating infrastructure and operational capabilities.
However, always verify that the facility is suitably licensed and equipped for the exact products being considered.
4. Flexible Product Portfolio Development
Third party manufacturing may allow businesses to explore different formulations, strengths and packaging formats through one or more manufacturing partners.
For example, a company may wish to expand from conventional tablets into capsules, syrups or topical formulations, subject to the manufacturer’s capabilities and applicable approvals.
The feasibility of each product should be assessed individually.
5. Greater Focus on Sales and Distribution
A pharmaceutical business must manage many activities beyond manufacturing, including market research, customer service, sales development, inventory planning and distribution.
Outsourcing eligible manufacturing activities can help the business focus more attention on these commercial responsibilities.
Nevertheless, outsourcing manufacturing does not automatically remove the commissioning company’s own regulatory or product-related obligations.
6. Potential for Business Expansion
As demand grows, a company can discuss larger production batches, additional products or new packaging configurations with its manufacturing partner.
Careful demand forecasting, inventory planning and supplier coordination are important to ensure that expansion remains commercially sustainable.
Types of Products Available for Third Party Pharma Manufacturing
The products available depend on the manufacturer’s infrastructure, licences, approved product scope and technical capabilities.
Common pharmaceutical dosage forms include:
Tablets
Tablets are widely used across many therapeutic categories. Depending on the facility’s capabilities, options may include conventional tablets, film-coated tablets and other approved tablet formulations.
Capsules
Capsule formulations are used for various pharmaceutical ingredients and dosage requirements. Manufacturers should confirm the available capsule types, formulation capabilities and packaging options.
Syrups and Oral Liquids
Liquid formulations may include syrups, oral solutions and suspensions, where supported by the manufacturing facility.
Product stability, preservation, packaging compatibility and applicable testing requirements are important considerations.
Softgel Capsules
Softgel capsules are used for suitable liquid or semi-solid fills. Manufacturing requires appropriate equipment and process controls, so confirm that the proposed partner can handle the specific formulation.
Ointments, Creams and Gels
Topical pharmaceutical products require suitable manufacturing and packaging capabilities. Product specifications and quality controls should be appropriate for the formulation and intended use.
Other Specialised Dosage Forms
Certain manufacturers may offer additional dosage forms, including sterile products or specialised formulations. These products require specific infrastructure, permissions and quality controls.
Never assume that a manufacturer supports every dosage form simply because it offers general pharmaceutical manufacturing.
Pharmaceutical Third Party Manufacturing vs In-House Manufacturing
Both approaches can be suitable, depending on a company’s strategy, scale and available resources.
| Factor | Third Party Manufacturing | In-House Manufacturing |
|---|---|---|
| Initial investment | May reduce infrastructure investment | Requires investment in facilities and equipment |
| Production operations | Managed under an external arrangement | Managed internally |
| Manufacturing control | Defined through agreements and oversight | More direct operational control |
| Product flexibility | Depends on the partner’s capabilities | Depends on internal infrastructure |
| Operational responsibility | Shared according to applicable obligations | Primarily managed within the organisation |
| Best suited for | Businesses seeking external manufacturing capabilities | Businesses needing direct production control and sufficient scale |
Third party manufacturing is not automatically cheaper in every situation. Businesses should compare the complete cost of outsourcing with the investment and operating expenses associated with in-house production.
How Much Does Third Party Pharma Manufacturing Cost in India?
There is no single standard price for third party pharmaceutical manufacturing. Costs vary considerably according to the product and the manufacturing arrangement.
The major cost factors include:
1. Formulation and Ingredients
Different formulations require different active ingredients, excipients, processing methods and testing procedures. Ingredient prices and availability can significantly affect the quotation.
2. Order Quantity
The production batch size and order quantity influence manufacturing economics. Larger orders may reduce certain per-unit costs, but they also increase inventory requirements and working capital.
3. Packaging Specifications
Packaging materials, printing, labels, cartons, bottles, blisters and special packaging requirements can affect the final price.
4. Quality and Testing Requirements
Product-specific testing, documentation, validation and other applicable quality requirements contribute to manufacturing costs.
5. Transportation and Delivery
Freight, insurance where applicable, delivery distance and dispatch arrangements should be considered when comparing quotations.
6. Commercial Terms
Payment schedules, taxes, lead times, raw material price changes and other contractual conditions may affect the overall commercial arrangement.
Practical tip: Request an itemised quotation for each product. Compare the same formulation, strength, pack size, quantity, packaging specifications and applicable quality requirements rather than choosing a supplier on price alone.
How to Choose the Best Third Party Pharmaceutical Manufacturer in India
Selecting a manufacturing partner is one of the most important decisions in building a pharmaceutical business.
1. Verify Manufacturing Licences
Confirm that the facility holds the appropriate manufacturing licence for the proposed products and activities. Where applicable, verify relevant product permissions and the status of the manufacturing site.
India’s pharmaceutical regulatory framework includes the Drugs and Cosmetics Act, 1940, the Drugs Rules, 1945, and requirements administered by the relevant central and state authorities.
The Central Drugs Standard Control Organisation (CDSCO) provides official information about applicable regulatory responsibilities and online regulatory services.
2. Evaluate GMP and Quality Systems
Good Manufacturing Practices help establish controls over pharmaceutical production and quality.
Review the manufacturer’s relevant GMP documentation, inspection history where available, quality procedures, testing arrangements and document-control practices.
If a manufacturer claims WHO-GMP certification or another certification, verify its validity, issuing authority, scope and applicability to the facility and products concerned.
A certificate should not be treated as proof that every product or manufacturing activity is automatically approved.
3. Review Manufacturing Capabilities
Confirm that the manufacturer has the equipment, technical expertise and facilities needed for the required dosage forms.
Ask about production capacity, batch sizes, packaging options, testing capabilities and the handling of product-specific requirements.
4. Check Product Quality Documentation
Discuss the documents that will be supplied for each batch, as applicable. These may include certificates of analysis, batch manufacturing records, batch packaging records and relevant release documentation.
Agree on the procedures for deviations, out-of-specification results, complaints, recalls and corrective actions.
5. Assess Communication and Reliability
A reliable partner should communicate clearly about quotations, production timelines, artwork approval, documentation and dispatch.
Ask how order status will be communicated and how delays or changes will be managed.
6. Clarify Pricing and Minimum Order Quantities
Request written confirmation of the minimum order quantity for each product. MOQs can vary by formulation, production process and packaging.
Ensure the quotation clearly describes the agreed product specifications and commercial terms.
7. Discuss Confidentiality and Intellectual Property
If you are developing a proprietary formulation, brand or packaging concept, clarify ownership, confidentiality, permitted use and restrictions in a written agreement.
The contract should also address product changes, artwork approval, records, complaints and responsibilities for regulatory compliance.
Documents and Regulatory Requirements to Consider
The documents needed for a third party manufacturing arrangement depend on the product, the parties involved and the applicable legal framework.
Before proceeding, confirm which of the following are relevant:
- Valid manufacturing licences and applicable product permissions.
- Relevant business registrations and tax documentation.
- Brand, trademark or authorisation documents, where applicable.
- Approved product specifications and packaging artwork.
- Purchase orders and manufacturing agreements.
- Quality agreements and applicable testing or release documents.
- Batch traceability and distribution records.
- Procedures for complaints, adverse events where applicable, and product recalls.
This is a general checklist, not a complete legal or regulatory document list for every situation.
Pharmaceutical products, nutraceuticals and food supplements may be subject to different regulatory requirements. Nutraceutical products regulated as foods, for example, require assessment under the applicable Food Safety and Standards Authority of India (FSSAI) framework rather than being treated automatically as pharmaceutical drugs.
Consult the relevant licensing authority or a qualified regulatory professional to establish the requirements for your particular product and business model.
Common Mistakes to Avoid in Third Party Pharma Manufacturing
Businesses can reduce avoidable problems by addressing key issues before confirming an order.
Choosing a manufacturer only on price: An unusually low quotation may not reflect the complete product specification, packaging, testing or delivery requirements.
Ignoring documentation: Confirm licences, product permissions and required records before production.
Approving artwork without proper review: Incorrect product information, claims or labelling can create regulatory and commercial problems.
Ordering without demand forecasting: Excess stock can tie up working capital and create expiry-related losses.
Failing to define quality responsibilities: Agree on specifications, batch release, complaints, investigations and recall procedures.
Assuming every product is available: Manufacturing capabilities differ by facility, dosage form and regulatory scope.
Overlooking contractual terms: Clarify payment, lead times, confidentiality, intellectual property, rejected batches and dispute resolution in writing.
A structured supplier evaluation process can help businesses establish more transparent and sustainable manufacturing relationships.
Why Consider Krone Biocare for Third Party Manufacturing?
Krone Biocare is a pharmaceutical, nutraceutical and Ayurvedic third party manufacturing business. Companies exploring external manufacturing can use the initial enquiry process to discuss their proposed products, packaging requirements and business objectives.
When evaluating Krone Biocare or any potential manufacturing partner, buyers should confirm the relevant product range, manufacturing arrangements, facility documentation, quality standards, minimum order quantities and commercial terms for their specific requirements.
Potential discussion areas include:
- Pharmaceutical manufacturing requirements.
- Nutraceutical product development and manufacturing.
- Ayurvedic product manufacturing requirements.
- Product portfolio planning and packaging specifications.
- Manufacturing quotations and order coordination.
- Documentation and quality requirements relevant to the proposed products.
The exact services available should be confirmed directly with the company for each product category.
If you are planning to launch a pharmaceutical brand, expand an existing portfolio or explore contract manufacturing options, preparing a clear product list and order estimate can make the initial discussion more productive.
Explore the relevant manufacturing services and product categories on the Krone Biocare website to identify the most appropriate enquiry route.
Conclusion
Third party pharma manufacturing in India can provide a practical route for pharmaceutical businesses seeking external production capabilities without establishing their own manufacturing facility.
The model can support brand development, product portfolio expansion and a greater focus on sales and distribution. Its success, however, depends on choosing a suitable manufacturing partner, verifying the relevant licences, agreeing on product specifications, maintaining appropriate quality oversight and understanding the applicable regulatory responsibilities.
Before placing an order, compare quotations carefully, review documentation, clarify commercial terms and establish clear procedures for quality, traceability and product complaints.
For pharmaceutical businesses considering their next product launch, a well-planned third party manufacturing arrangement can form an important part of a sustainable business strategy.
Looking for third party pharma manufacturing solutions? Visit Krone Biocare to explore the company’s manufacturing offerings and enquire about your product requirements.
Frequently Asked Questions (FAQs)
1. What is third party pharma manufacturing in India?
Third party pharma manufacturing is an arrangement in which a business engages an appropriately licensed manufacturer to produce pharmaceutical products under agreed commercial, technical and regulatory conditions.
2. What are the benefits of third party pharmaceutical manufacturing?
Potential benefits include reduced investment in manufacturing infrastructure, access to external production capabilities, opportunities to develop branded products and greater focus on sales and distribution.
3. How do I choose a third party pharma manufacturer in India?
Check applicable manufacturing licences, product permissions, quality systems, manufacturing capabilities, documentation, pricing, delivery timelines and contractual terms before selecting a partner.
4. What is the minimum order quantity for third party medicine manufacturing?
The minimum order quantity varies by product, formulation, batch size and packaging requirements. Ask the manufacturer for a written, product-specific quotation.
5. Is third party pharma manufacturing suitable for startups?
It can be suitable for eligible startups and pharmaceutical marketing businesses that want to explore branded products without establishing their own manufacturing plant. Regulatory, financial and distribution requirements should be assessed first.
6. What documents are required for third party pharmaceutical manufacturing?
Requirements vary by product and arrangement. They may include applicable licences, product permissions, business documents, brand authorisations, product specifications, manufacturing agreements and quality documentation.
7. What is the difference between third party manufacturing and contract manufacturing?
The terms are often used interchangeably in commercial discussions. However, specific legal structures, licensing requirements and responsibilities can differ, so the proposed arrangement should be reviewed carefully.
8. Can I manufacture nutraceutical products through a third party manufacturer?
Yes, subject to the manufacturer’s capabilities and applicable regulatory requirements. Nutraceutical products regulated as foods may require FSSAI-related compliance, which differs from the regulatory framework for pharmaceutical drugs.
9. Does third party manufacturing guarantee lower costs?
No. It may reduce infrastructure investment, but the overall cost depends on order quantity, formulation, packaging, quality requirements, logistics and commercial terms.
10. How can I enquire about third party manufacturing with Krone Biocare?
Visit www.kronebiocare.com and explore the relevant manufacturing services. Prepare your product list, specifications, estimated quantities and packaging requirements for an informed discussion.
BY KRONE BIOCARE (WHO-GMP Certified Mfg Co.)